Form 4: Ralph Alvarez Reports LLY Stock Transactions

Ralph Alvarez, a Director at Eli Lilly & Co., reported a transaction involving the acquisition of 13.498 shares of common stock, valued at $919.90 per share, as part of a deferred compensation plan.

Summary

• Director Ralph Alvarez acquired 13.498 shares of Eli Lilly & Co. common stock on April 20, 2026.
• The acquisition was made under the Lilly Directors' Deferral Plan, where shares are deferred in lieu of cash compensation.
• These deferred shares will be settled in common stock upon Mr. Alvarez's separation from service.
• Following the transaction, Mr. Alvarez beneficially owns 55,614.713 shares of common stock directly.
• An additional 758 shares are held indirectly through a trust, for which Mr. Alvarez disclaims beneficial ownership beyond his pecuniary interest.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard disclosure of director compensation and stock deferral, with no indication of positive or negative company performance.

Positives

• Director Ralph Alvarez continues to hold a significant beneficial ownership in Eli Lilly & Co., with 55,614.713 shares held directly and 758 indirectly.
• The transaction reflects a long-term incentive structure for directors, aligning their interests with shareholders through stock ownership.

Negatives

• The filing does not indicate any negative financial performance or operational issues for Eli Lilly & Co.

Risks

• The filing does not explicitly mention any current issues or potential future challenges for the company.

Future Outlook

The acquired shares are deferred under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

StockSavvy.ai notes that this Form 4 filing by a director of Eli Lilly & Co. is a routine disclosure of stock transactions, reflecting standard corporate governance practices for executive and director compensation and ownership.

Corporate Governance

Stakeholder Impact

• Shareholders: The transaction reinforces director alignment with shareholder interests through stock ownership and deferred compensation.
• Employees: Indirect impact through the company's compensation structure for its directors.
• Management: Standard practice for director compensation and ownership reporting.

Next Steps

• Settlement of deferred shares in common stock following the reporting person's separation from service.

Key Dates

Keywords

Eli Lilly & Co., LLY, Form 4, Director, Stock Acquisition, Deferred Compensation, Beneficial Ownership, Securities Exchange Act